Patients with AML are monitored regularly, initially on a monthly basis, then every three months and finally yearly. This allows detection of signs of relapse or complications. It is important to emphasise to patients the need to report any new symptoms or concerning side effects as soon as possible.
Login
Accessing this course requires a login. Please enter your credentials below!
